| Issue Date | Title | Author(s) |
| 2014-06 | Animal models of chronic obstructive pulmonary disease. | Fricker, M; Deane, A; Hansbro, PM |
| 2014-01 | Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis. | Jaffar, J; Unger, S; Corte, TJ; Keller, M; Wolters, PJ; Richeldi, L; Cerri, S; Prêle, CM; Hansbro, PM; Argraves, WS; Oliver, RA; Oliver, BG; Black, JL; Burgess, JK |
| 2007-09 | Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. | Horvat, JC; Beagley, KW; Wade, MA; Preston, JA; Hansbro, NG; Hickey, DK; Kaiko, GE; Gibson, PG; Foster, PS; Hansbro, PM |
| 2018-10-01 | Identification of a plasma microRNA profile in untreated pulmonary tuberculosis patients that is modulated by anti-mycobacterial therapy | Barry, SE; Ellis, M; Yang, YR; Guan, G; Wang, X; Britton, WJ; Saunders, BM |
| 2014-01-01 | Viral infections and asthma: An inflammatory interface? | Oliver, BGG; Robinson, P; Peters, M; Black, J |
| 2022-02 | Role of Suppressor of cytokine signaling 2 during the development and resolution of an experimental arthritis. | Cramer, A; Galvão, I; Venturini de Sá, N; Gaio, P; Fernanda de Melo Oliveira, N; Rates Gonzaga Santos, M; Henrique Campolina-Silva, G; Vinicius Santos Valiate, B; Rezende Souza, F; Dantas Cassali, G; Martins Teixeira, M; Almeida Amaral, F; Simão Machado, F |
| 2021-05 | Rapid progression is associated with lymphoid follicle dysfunction in SIV-infected infant rhesus macaques. | Wood, MP; Jones, CI; Lippy, A; Oliver, BG; Walund, B; Fancher, KA; Fisher, BS; Wright, PJ; Fuller, JT; Murapa, P; Habib, J; Mavigner, M; Chahroudi, A; Sather, DN; Fuller, DH; Sodora, DL |
| 2021-04-05 | Integrative microbiomics in bronchiectasis exacerbations | Mac Aogáin, M; Narayana, JK; Tiew, PY; Ali, NABM; Yong, VFL; Jaggi, TK; Lim, AYH; Keir, HR; Dicker, AJ; Thng, KX; Tsang, A; Ivan, FX; Poh, ME; Oriano, M; Aliberti, S; Blasi, F; Low, TB; Ong, TH; Oliver, B; Giam, YH; Tee, A; Koh, MS; Abisheganaden, JA; Tsaneva-Atanasova, K; Chalmers, JD; Chotirmall, SH |
| 2018-11 | Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations. | Choi, JP; Wang, R; Yang, X; Wang, X; Wang, L; Ting, KK; Foley, M; Cogger, V; Yang, Z; Liu, F; Han, Z; Liu, R; Baell, J; Zheng, X |
| 2020-01-14 | Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C. | Tanwar, S; Rhodes, F; Srivastava, A; Trembling, PM; Rosenberg, WM |
